Key model of pulmonary fibrosis drug development
Due to the lack of clinically effective drugs for the treatment of pulmonary fibrosis, there is an urgent need to explore its pathogenesis, and the establishment of a suitable experimental animal model of pulmonary fibrosis plays an important role. At present, KCI has established a pulmonary fibrosis model induced by Bleomycin and Silica.We hope to use KCI's comprehensive respiratory disease research technology to help you implement the research of treatment drugs for pulmonary fibrosis disease, meet the unique challenges in the field of lung disease, and meet your new drug development requirements.
If you have project needs and experience our more professional services, please contact us.
Our service
Type | Model setting | Animals |
Pulmonary fibrosis model | Bleomycin-induced bilateral lung fibrosis model in mouse | Mouse |
Bleomycin-induced unilateral pulmonary fibrosis in rats | Rat | |
Silica-induced model | Rat、Mouse |
案例分享
博莱霉素诱导的小鼠肺纤维化模型
BLM induced mouse lung fibrosis model
博来霉素诱导的大鼠单侧肺纤维化模型
BLM induced rat unilateral lung fibrosis model
二氧化硅诱导的大鼠肺纤维化模型
Silicon induced lung fibrosis model on rodents
